StockData
Traws Pharma, Inc. logo

Traws Pharma, Inc. (TRAW) stock

TRAWNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 5/30
$0.23−0.03 (-10.27%)

Close on Nov 17, 2026Market cap $3.59MP/E –Yield –

Traws Pharma operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Traws Pharma's operating cash flow for the twelve months ending Jun 30, 2026 was -$16.85M. For fiscal 2025 it was -$18.19M. The highest annual figure on record is $1.63M in fiscal 2012.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$18.19M–
FY2024Dec 31, 2024-$29.79M–
FY2023Dec 31, 2023-$17.93M–
FY2022Dec 31, 2022-$16.29M–
FY2021Dec 31, 2021-$19.49M–
FY2020Dec 31, 2020-$23.08M–
FY2019Dec 31, 2019-$20.83M–
FY2018Dec 31, 2018-$22.70M–
FY2017Dec 31, 2017-$23.82M–
FY2016Dec 31, 2016-$15.81M–
FY2015Dec 31, 2015-$31.24M–
FY2014Dec 31, 2014-$57.65M–
FY2013Dec 31, 2013-$61.38M-3859.0%
FY2012Dec 31, 2012$1.63M–
FY2011Dec 31, 2011-$14.17M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$7.50M–
Q1 FY2026Mar 31, 2026-$2.58M–
Q4 FY2025Dec 31, 2025-$2.76M–
Q3 FY2025Sep 30, 2025-$4.01M–
Q2 FY2025Jun 30, 2025-$5.98M–
Q1 FY2025Mar 31, 2025-$5.44M–
Q4 FY2024Dec 31, 2024-$4.04M–
Q3 FY2024Sep 30, 2024-$11.48M–
Q2 FY2024Jun 30, 2024-$9.85M–
Q1 FY2024Mar 31, 2024-$4.42M–
Q4 FY2023Dec 31, 2023-$4.43M–
Q3 FY2023Sep 30, 2023-$4.47M–
Q2 FY2023Jun 30, 2023-$4.49M–
Q1 FY2023Mar 31, 2023-$4.54M–
Q4 FY2022Dec 31, 2022-$3.88M–
Q3 FY2022Sep 30, 2022-$3.90M–
Q2 FY2022Jun 30, 2022-$4.21M–
Q1 FY2022Mar 31, 2022-$4.30M–
Q4 FY2021Dec 31, 2021-$4.27M–
Q3 FY2021Sep 30, 2021-$4.27M–
Q2 FY2021Jun 30, 2021-$4.31M–
Q1 FY2021Mar 31, 2021-$6.65M–
Q4 FY2020Dec 31, 2020-$5.47M–
Q3 FY2020Sep 30, 2020-$5.76M–
Q2 FY2020Jun 30, 2020-$5.38M–
Q1 FY2020Mar 31, 2020-$6.46M–
Q4 FY2019Dec 31, 2019-$5.36M–
Q3 FY2019Sep 30, 2019-$3.96M–
Q2 FY2019Jun 30, 2019-$4.91M–
Q1 FY2019Mar 31, 2019-$6.60M–
Q4 FY2018Dec 31, 2018-$5.41M–
Q3 FY2018Sep 30, 2018-$7.15M–
Q2 FY2018Jun 30, 2018-$4.62M–
Q1 FY2018Mar 31, 2018-$5.51M–
Q4 FY2017Dec 31, 2017-$4.67M–
Q3 FY2017Sep 30, 2017-$7.40M–
Q2 FY2017Jun 30, 2017-$5.69M–
Q1 FY2017Mar 31, 2017-$6.06M–
Q4 FY2016Dec 31, 2016-$4.36M–
Q3 FY2016Sep 30, 2016-$2.86M–

More Traws Pharma figures

See a number that looks wrong?